The role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow.

Journal: Interventional medicine & applied science
Published Date: Dec 1, 2016

Abstract

BACKGROUND: Slow coronary flow (SCF) is an angiographic finding characterized with delayed opacification of epicardial coronary arteries without obstructive coronary disease. Urotensin II (UII) is an important vascular peptide, which has an important role in hypertension, coronary artery disease, and vascular remodeling in addition to potent vasoconstrictor effect.

Authors

  • Ömer Şatıroğlu
    Department of Cardiology, Faculty of Medicine, Recep Tayyip Erdoğan University , Rize, Turkey.
  • Murtaza Emre Durakoğlugil
    Department of Cardiology, Faculty of Medicine, Recep Tayyip Erdoğan University , Rize, Turkey.
  • Mustafa Çetin
    Department of Cardiology, Faculty of Medicine, Recep Tayyip Erdoğan University , Rize, Turkey.
  • Yüksel Çiçek
    Department of Cardiology, Faculty of Medicine, Recep Tayyip Erdoğan University , Rize, Turkey.
  • Turan Erdoğan
    Department of Cardiology, Faculty of Medicine, Recep Tayyip Erdoğan University , Rize, Turkey.
  • Hakan Duman
    Department of Cardiology, Faculty of Medicine, Recep Tayyip Erdoğan University , Rize, Turkey.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals